BioCentury
ARTICLE | Company News

Neuralstem, Sumitomo Corp. Group deal

June 13, 2011 7:00 AM UTC

Neuralstem granted Sumitomo's Summit Pharmaceuticals International Corp. subsidiary exclusive rights to seek a partner on Neuralstem's behalf for the development of NSI-189 in Japan. The small molec...